Construction of a dual affinity tagged allele of the Rb1 tumor suppressor gene in the mouse

Genesis

Volumn 48, Issue 2, 2010, Pages 121-126

  Xiao, Hai ^a   Zhang, Xiaojing ^a   Goodrich, David W ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Affinity purification; Cell cycle; Development; Tumor suppressor

Indexed keywords

PROTEIN; RB1 PROTEIN; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ALLELE; ANIMAL EXPERIMENT; ARTICLE; CANCER INHIBITION; GENE FUNCTION; GENE TARGETING; IN VIVO STUDY; MOLECULAR INTERACTION; MOLECULAR MECHANICS; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN PURIFICATION; SOMATIC CELL GENETICS; TUMOR SUPPRESSOR GENE; WILD TYPE;

ALLELES; ANIMALS; CHIMERA; CHROMATOGRAPHY, AFFINITY; CROSSES, GENETIC; EXONS; GENES, TUMOR SUPPRESSOR; HOMOZYGOTE; INTRONS; MICE; MICE, INBRED C57BL; MODELS, GENETIC; RETINOBLASTOMA PROTEIN;

EID: 77249146906     PISSN: 1526954X     EISSN: 1526968X     Source Type: Journal    
DOI: 10.1002/dvg.20589     Document Type: Article

References (26)

1. Acquaviva A, Ciccolallo L, Rondelli R, Balistreri A, Ancarola R, Cozza R, Hadjistilianou D, Francesco SD, Toti P, Pastore G, Haupt R, Carli M, Santoro N, Cataldo AD, Fiorillo A, Indolfi P, Nucci P, Sandri A, Porta F, Porcaro AB, Tamaro P, Morgese G. 2006. Mortality from second tumour among long-term survivors of retinoblastoma: A retrospective analysis of the Italian retinoblastoma registry. Oncogene 25:5350-5357.
2. Attwooll C, Denchi EL, Helin K. 2004. The E2F family: Specific functions and overlapping interests. EMBO J 23:4709-4716.
3. Bracken AP, Ciro M, Cocito A, Helin K. 2004. E2F target genes: Unraveling the biology. Trends Biochem Sci 29:409-417.
4. Burkhart DL, Sage J. 2008. Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat Rev Cancer 8:671-682.
5. Connell-Crowley L, Harper JW, Goodrich DW. 1997. Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by sitespecific phosphorylation. Mol Biol Cell 8:287-301.
6. Eng C, Li FP, Abramson DH, Ellsworth RM, Wong FL, Goldman MB, Seddon J, Tarbell N, Boice JD Jr. 1993. Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst 85:1121-1128
7. Forler DK. 2003. An efficient protein complex purification method for functional proteomics in higher eukaryotes. Nat Biotechnol 21:89-92.
8. Goodrich DW. 2006. The retinoblastoma tumor-suppressor gene, the exception that proves the rule. Oncogene 25:5233-5243.
9. Gregan J, Riedel CG, Petronczki M, Cipak L, Rumpf C, Poser I, Buchholz F, Mechtler K, Nasmyth K, Gregan J, Riedel CG, Petronczki M, Cipak L, Rumpf C, Poser I, Buchholz F, Mechtler K, Nasmyth K. 2007. Tandem affinity purification of functional TAP-tagged proteins from human cells. Nature Protocols 2:1145-1151.
10. Hansen MF, Koufos A, Gallie BL, Phillips RA, Fodstad O, Brogger A, Gedde-Dahl T, Cavenee WK. 1985. Osteosarcoma and retinoblastoma: A shared chromosomal mechanism revealing recessive predisposition. Proc Natl Acad Sci USA 82:6216-6220.
11. Harbour JW. 2001. Molecular basis of low-penetrance retinoblastoma. Arch Ophthalmol 119:1699-1704.
12. Koch HB, Zhang R, Verdoodt B, Bailey A, Zhang CD, Yates JR, 3rd, Menssen A, Hermeking H, Koch HB, Zhang R, Verdoodt B, Bailey A, Zhang C-D, Yates JR, 3rd, Menssen A, Hermeking H. 2007.
13. Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. Cell Cycle 6:205-217.
14. Krogan NJ, Cagney G, Yu H, Zhong G, Guo X, Ignatchenko A, Li J, Pu S, Datta N, Tikuisis AP, Punna T, Peregrin-Alvarez JM, Shales M, Zhang X, Davey M, Robinson MD, Paccanaro A, Bray JE, Sheung A, Beattie B, Richards DP, Canadien V, Lalev A, Mena F, Wong P, Starostine A, Canete MM, Vlasblom J, Wu S, Orsi C, Collins SR, Chandran S, Haw R, Rilstone JJ, Gandi K, Thompson NJ, Musso G, St Onge P, Ghanny S, Lam MH, Butland G, Altaf-Ul AM, Kanaya S, Shilatifard A, O'shea E, Weissman JS, Ingles CJ, Hughes TR, Parkinson J, Gerstein M, Wodak SJ, Emili A, Greenblatt JF. 2006. Global landscape of protein complexes in the yeast Saccharomyces cerevisiae. Nature 440:637-643.
15. Lambert JP, Mitchell L, Rudner A, Baetz K, Figeys D, Lambert J-P, Mitchell L, Rudner A, Baetz K, Figeys D. 2009. A novel proteomics approach for the discovery of chromatin-associated protein networks. Mol Cell Proteomics 8:870-882.
16. Lee EY, Cam H, Ziebold U, Rayman JB, Lees JA, Dynlacht BD. 2002. E2F4 loss suppresses tumorigenesis in Rb mutant mice. Cancer Cell 2:463-472.
17. Malumbres M, Barbacid M. 2001. To cycle or not to cycle: A critical decision in cancer. Nat Rev Cancer 1:222-231.
18. Morris EJ, Dyson NJ. 2001. Retinoblastoma protein partners. Adv Cancer Res 82:1-54.
19. Sherr CJ. 2000. The Pezcoller lecture: Cancer cell cycles revisited. Cancer Res 60:3689-3695.
20. Stengel KR, Thangavel C, Solomon DA, Angus SP, Zheng Y, Knudsen ES. 2009. Retinoblastoma/p107/p130 pocket proteins: Protein dynamics and interactions with target gene promoters. J Biol Chem 284:19265-19271.
21. Sun H, Chang Y, Schweers B, Dyer MA, Zhang X, Hayward SW, Goodrich DW. 2006. An E2F binding-deficient Rb1 protein partially rescues developmental defects associated with Rb1 nullizygosity. Mol Cell Biol 26:1527-1537.
22. Tallquist MD, Soriano P. 2000. Epiblast-restricted Cre expression in MORE mice: A tool to distinguish embryonic vs. extra-embryonic gene function. Genesis 26:113-115.
23. Wells J, Yan PS, Cechvala M, Huang T, Farnham PJ. 2003. Identification of novel pRb binding sites using CpG microarrays suggests that E2F recruits pRb to specific genomic sites during S phase. Oncogene 22:1445-1460.
24. Wikenheiser-Brokamp KA, Wikenheiser-Brokamp KA. 2006. Retinoblastoma family proteins: Insights gained through genetic manipulation of mice. Cell Mol Life Sci 63:767-780.
25. Yamasaki L, Bronson R, Williams BO, Dyson NJ, Harlow E, Jacks T. 1998. Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(1/-)mice. Nat Genet 18:360-364.
26. Ziebold U, Lee EY, Bronson RT, Lees JA. 2003. E2F3 loss has opposing effects on different pRB-deficient tumors, resulting in suppression of pituitary tumors but metastasis of medullary thyroid carcinomas. Mol Cell Biol 23:6542-6552.